α-helix structure in Alzheimer's disease aggregates of tau-protein

被引:101
|
作者
Sadqi, M
Hernández, F
Pan, UM
Pérez, M
Schaeberle, MD
Avila, J
Muñoz, V
机构
[1] Univ Maryland, Dept Chem & Biochem, College Pk, MD 20742 USA
[2] Univ Maryland, Ctr Biomol Struct & Org, College Pk, MD 20742 USA
[3] Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa, E-28049 Madrid, Spain
[4] NIDDKD, Phys Chem Lab, NIH, Bethesda, MD 20892 USA
关键词
D O I
10.1021/bi025777e
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The discovery of beta-sheet structure in Alzheimer's amyloid fibrils, and then in many other disease-related protein fibrils, has led to the widely believed view that beta-sheet formation is the general mechanism of aberrant protein aggregation leading to disease. This notion is further reinforced by recent findings, which indicate that normal proteins can be induced to form beta-sheet fibrils in vitro. Alzheimer's disease, a paradigm proteopathy, is accompanied by the formation of two distinct aggregates, amyloid fibrils and paired helical filaments (PHFs). Electron microscope images of PHFs show pairs of twisted ribbons with 80 nm periodicity. However, there is little information of the molecular structure of PHFs, as previous studies have failed to identify signs of regular structure. Using far-UV circular dichroism and Fourier-transformed infrared spectroscopy, we find that PHFs are comprised of alpha-helices. This is remarkable as tau-protein, PHF's primary constituent, has a high abundance of helix-breaking amino acids and is unstructured in solution. We also find that PHFs are very stable, as judged by their high melting temperature and resistance to protease digestion. PHFs are the first example of pathological aggregation associated to the formation of alpha-helix.
引用
收藏
页码:7150 / 7155
页数:6
相关论文
共 50 条
  • [31] Tau protein's role in Alzheimer's disease
    不详
    CHEMICAL & ENGINEERING NEWS, 2007, 85 (02) : 44 - 44
  • [32] ALTERED PHOSPHORYLATION OF TAU-PROTEIN IN HEAT-SHOCKED RATS AND PATIENTS WITH ALZHEIMER-DISEASE
    PAPASOZOMENOS, SC
    SU, Y
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (10) : 4543 - 4547
  • [33] ALUMINUM, TAU-PROTEIN, AND ALZHEIMERS-DISEASE - REPLY
    HARRINGTON, CR
    WISCHIK, CM
    MCARTHUR, FK
    TAYLOR, GA
    EDWARDSON, JA
    CANDY, JM
    LANCET, 1994, 344 (8916): : 205 - 205
  • [34] The evaluation of tau-protein in the CSF in patients suffering from Parkinson's disease
    Vranova, H.
    Kanovsky, P.
    Nevrly, M.
    Mares, J.
    Hlustik, P.
    MOVEMENT DISORDERS, 2007, 22 : S178 - S178
  • [35] TAU-PROTEIN AND THE NEUROFIBRILLARY PATHOLOGY OF ALZHEIMERS-DISEASE
    GOEDERT, M
    TRENDS IN NEUROSCIENCES, 1993, 16 (11) : 460 - 465
  • [36] The evaluation of tau-protein in the CSF of patients suffering from Parkinson's disease
    Vranova, H.
    Mares, J.
    Nevrli, M.
    Herzig, R.
    Kanovsky, P.
    JOURNAL OF NEUROLOGY, 2007, 254 : 124 - 124
  • [37] ALZHEIMER'S DISEASE Structure of aggregates revealed
    Tycko, Robert
    NATURE, 2016, 537 (7621) : 492 - 493
  • [38] CHARACTERIZATION OF 2 PATHOLOGICAL TAU-PROTEIN VARIANTS IN ALZHEIMER BRAIN CORTICES
    FLAMENT, S
    DELACOURTE, A
    HEMON, B
    DEFOSSEZ, A
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 1989, 92 (2-3) : 133 - 141
  • [39] Alzheimer disease hyperphosphorylated tau aggregates hydrophobically
    Ruben, GC
    Ciardelli, TL
    GrundkeIqbal, I
    Iqbal, K
    SYNAPSE, 1997, 27 (03) : 208 - 229
  • [40] MAP KINASE TRANSFORMS TAU-PROTEIN INTO AN ALZHEIMER-LIKE STATE
    DREWES, G
    LICHTENBERGKRAAG, B
    DORING, F
    MANDELKOW, EM
    BIERNAT, J
    GORIS, J
    DOREE, M
    MANDELKOW, E
    MOLECULAR BIOLOGY OF THE CELL, 1992, 3 : A164 - A164